(Q34087512)

30 July 2017

title

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element (English)

1 reference

30 July 2017

Tagat JR

1

1 reference

30 July 2017

McCombie SW

2

1 reference

30 July 2017

Steensma RW

3

1 reference

30 July 2017

Lin S

4

1 reference

30 July 2017

Nazareno DV

5

1 reference

30 July 2017

Baroudy B

6

1 reference

30 July 2017

Vantuno N

7

1 reference

30 July 2017

Xu S

8

1 reference

30 July 2017

Liu J

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

30 July 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

issue

16

1 reference

30 July 2017

page(s)

2143-2146

1 reference

HIV-1 drug resistance in newly infected individuals

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Chemokine receptors: keys to AIDS pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Viral exploitation and subversion of the immune system through chemokine mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Opportunities for novel therapeutic agents acting at chemokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

HIV-1 entry - an expanding portal for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900381-X

7 January 2021

10.1016/S0960-894X(01)00381-X

Identifiers

DOI

1 reference

30 July 2017

1 reference